These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3873156)

  • 41. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative study of acute and chronic effects of nifedipine in patients with secondary pulmonary hypertension].
    Dubiel JP; Nikodemowicz M; Zmudka K; Mazurek S; Królikowski T
    Kardiol Pol; 1991; 34(5):279-86. PubMed ID: 1921110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
    Geggel RL; Dozor AJ; Fyler DC; Reid LM
    Am Rev Respir Dis; 1985 Apr; 131(4):531-6. PubMed ID: 3994148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
    Ren JH; Unverferth DV; Magorien RD; Leier CV
    Arch Intern Med; 1985 Apr; 145(4):641-4. PubMed ID: 3985726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nifedipine in the treatment of chronic cor pulmonale].
    Saadjian A; Philip-Joet F; Tran N'guyen A; Arnaud A; Torresani J
    Arch Mal Coeur Vaiss; 1986 Jan; 79(1):76-83. PubMed ID: 3085613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
    Ram J; Freedman SB; Ogasawara S; Thomson A; Kelly DT
    Am J Cardiol; 1989 Apr; 63(12):802-6. PubMed ID: 2929436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R; Bender F; Gülker H; Specker E; Molinski M
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic effects of nifedipine in normoxic and hypoxic newborn lambs.
    Philips JB; Lyrene RK; Leslie GI; McDevitt M; Cassady G
    Pediatr Pharmacol (New York); 1985; 5(1):23-30. PubMed ID: 3991251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
    Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M
    Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of nifedipine on systemic hydraulic vascular load in patients with hypertension.
    Chang KC; Hsieh KS; Kuo TS; Chen HI
    Cardiovasc Res; 1990 Sep; 24(9):719-26. PubMed ID: 2224939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
    Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H
    Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
    Prielipp RC; Rosenthal MH; Pearl RG
    Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
    Barst RJ
    Chest; 1986 Apr; 89(4):497-503. PubMed ID: 2869919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system.
    Bein T; Metz C; Keyl C; Sendtner E; Pfeifer M
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):583-6. PubMed ID: 8847877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paradoxical elevation of pulmonary vascular resistance after nifedipine in primary pulmonary hypertension. A case study.
    Pohar B; Grad A; Mozina M; Rakovec P; Horvat M
    Cor Vasa; 1989; 31(3):238-41. PubMed ID: 2766755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute and chronic effects of nitrendipine in patients with precapillary pulmonary hypertension due to pulmonary fibrosis.
    Burger W; Jandl M; Gellert J; Schultze-Werninghaus G; Kober G
    Clin Cardiol; 1991 Mar; 14(3):220-5. PubMed ID: 2013178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.